PUREtrace

PUREtracePUREtrace has been developed to use the most direct measure for uterine activity - the electrical muscle activity of the uterus - for fetal monitoring. By using the Graphium electrodepatch, reliable information is obtained in a comfortable and entirely safe way. As the PUREtrace can be connected directly with available fetal monitors, the new technology is available for hospitals without requiring large investments in new equipment.

At the patient side, PUREtrace is connected to the Graphium electrodepatch and at the other side PUREtrace is connected to the fetal monitor by a suitable connector. PUREtrace is available for the fetal monitors listed below:

  • Philips ‘1350’-series;

  • Philips Avalon FM30 and FM40 (from Q3 2012);

  • Neoventa STAN (from Q3 2012).